Filing Details
- Accession Number:
- 0001493152-23-021430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-15 16:15:18
- Reporting Period:
- 2023-06-14
- Accepted Time:
- 2023-06-15 16:15:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1106838 | Sonnet Biotherapeutics Holdings Inc. | SONN | Pharmaceutical Preparations (2834) | 522102141 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1806764 | Susan Dexter | 100 Overlook Center, Suite 102 Princeton, NJ 08540 | Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-14 | 10,000 | $0.70 | 33,667 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6972 to $0.6999 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- Includes unvested restricted stock awards.
Billionaire Hedge Funds
